Home > Name List By i > Immunoglobulin,anti-(human complement C5 a-chain) (human-mouse monoclonal 5G1.1 heavy chain), disulfide withhuman-mouse monoc...

CAS No 219685-50-4 , Immunoglobulin,anti-(human complement C5 a-chain) (human-mouse monoclonal 5G1.1 heavy chain), disulfide withhuman-mouse monoclonal 5G1.1 light chain, dimer (9CI)

Select to

219685-50-4 Eculizumab

  • Eculizumab
  • China Finechemie Co., Ltd. [Manufacturer]
  • Tel: +86-23-99186710
  • Fax: +86-23-99186729
  • Address: 28th Floor Mordern Building,New-Tech Zone400020 ChongqingCHINA Chongqing,nullChina
Contact Supplier

219685-50-4 ECULIZUMABUM

  • China Nanjing Chemlin Chemical Industry Co.,Ltd. [Manufacturer]
  • Tel: +86 25 8369-7070/ +86 138 51816776 (Mobile)
  • Fax: +86 25 8345-3275
  • Address: Rm.902 Longyin Plaza,
    No. 217 Zhongshan Rd.
    (N)Nanjing 210009,China null,nullChina
Contact Supplier

Select to

References of Immunoglobulin,anti-(human complement C5 a-chain) (human-mouse monoclonal 5G1.1 heavy chain), disulfide withhuman-mouse monoclonal 5G1.1 light chain, dimer (9CI)
Title: Eculizumab
CAS Registry Number: 219685-50-4
CAS Name: Anti-(human complement C5a-chain)(human-mouse monoclonal 5G1.1 heavy chain)immunoglobulin, disulfide with human-mouse monoclonal 5G1.1 light chain, dimer
Synonyms: h5G1.1 Fab; h5G1.1VHC + h5G1.1VLC
Literature References: Humanized monoclonal antibody directed against complement component C5; designed to prevent activation of complement-mediated inflammation and tissue injury. Prepn: M. J. Evans et al., WO 9529697; eidem, US 6355245 (1995, 2002 both to Alexion); and complement inhibition study: T. C. Thomas et al., Mol. Immunol. 33, 1389 (1996). Clinical evaluation in paroxysmal nocturnal hemoglobinuria: P. Hillmen et al., N. Engl. J. Med. 350, 552 (2004); A. Hill et al., Blood 106, 2559 (2005). Review of development and therapeutic potential: M. Kaplan, Curr. Opin. Invest. Drugs 3, 1017-1023 (2002).
Therap-Cat: Anti-inflammatory.
Keywords: Anti-inflammatory (Biological Response Modifier).